Sustained released oxycodone/naloxone for postoperative pain therapy after caesarean section

Sustained released oxycodone/naloxone for postoperative pain therapy after caesarean section - Oxycodone post caesaream

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00011332

Enrollment

140

Registered

2016-12-05

Start date

2013-04-14

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

O82

Interventions

Group 1: Patients after C-secion receive 2 h postoperativelyy Oxycdon 20 mg + Ibuprofen 600 mg, 14 h Oxycodon 10 mg + Ibuprofen 600 mg und und the conditions of persisting pain (NRS >4) 26 h postoper

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: - Age >18 years < 50 years - (ASA Physical Status I-III, classification der American Society of Anesthesiologists, 1963) - primary or secondary caesarean in spinal or epidural anesthesia - german language - informend consent

Exclusion criteria

Exclusion criteria: - Oxycodone / Ibuprofen /Paracetamol Allergy - preexisting chronic pain conditions - medication with opioid (substitution program)

Design outcomes

Primary

Measure	Time frame
postoperative pain intensity at rest 24h post caesarean Questionnaire ( numeric rating scale)	—

Secondary

Measure	Time frame
postoperative pain intensity 48h post caesarean Score for depression/fear/stress in DASS Wish for more analgesics Pain/therapy associated symptoms (disturbance of sleep/mood, fatigue, nausea/vomiting)	—

Countries

Germany

Contacts

Public ContactHenning Ohnesorge

UKSH, Campus Kiel, Klinik für Anästhesiologie und Operative Intensivmedizin

henning.ohnesorge@uksh.de0049 431 597 20801

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026